Ignite Creation Date:
2024-07-17 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477926
Status:
COMPLETED
Last Update Posted:
2024-06-27
First Post:
2024-06-24
Brief Title:
A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants
Sponsor:
AbbVie
Organization:
AbbVie
Study Overview
Official Title:
A Phase 1 Relative Bioavailability and Food Effect Study of ABBV-668 Extended-Release Formulations
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objectives of this study are to assess safety and tolerability of the new ABBV-668 ER tablets to assess the oral bioavailability of the ABBV-668 ER tablets relative to the ABBV-668 IR capsules and to assess the pharmacokinetics of the ER tablets under fasting and fed conditions in healthy adults
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None